Novel antibodies show promise for tumor targeting and RAD51 inhibition

A new research paper was published in Oncotarget’s Volume 15 on October 1, 2024, entitled, “Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition.”

Pα+ Psychedelic Bulletin #155: MAPS Invests in Numinus, Hopes to Offer Experiential Training for MDMA Therapists – Psychedelic Alpha

Featured content in this Issue: MAPS Invests in Numinus, Hopes to Offer Experiential Training for MDMA Therapists Long-Term Effects of Microdosing Remain Key Unknown; Cardiac

February 8, 2024

‘Critically Impactful’ Drug Shortages; Emotions and Cancer; CRC Clues in Microbiome

In a recent survey, almost a third of healthcare system pharmacists said drug shortages are “critically impacting” patient care. (CNN) Six months of aerobic exercise

August 11, 2023

WHO Unveils S.A.R.A.H.: An AI-Powered Digital Health Promoter

Meet S.A.R.A.H.: A Smart AI Resource Assistant for Health What You Should Know: – The World Health Organization (WHO) unveils S.A.R.A.H., an AI-powered digital health

April 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.